Dr. Hamid Emamekhoo is an Associate Professor of Hematology and Oncology at the University of Wisconsin Carbone Cancer Center, where he specializes in genitourinary cancers with a particular focus on kidney cancer. He cares for a high volume of patients with renal cell carcinoma and has contributed to national research efforts through his work with the ECOG-ACRIN Cooperative Group and other industry sponsored clinical trials. Dr. Emamekhoo also serves on the ASCO treatment guideline panel for kidney cancer, with the updated guideline published in 2024. His research focuses on developing novel biomarkers such as circulating tumor cells and circulating tumor DNA, advancing immunotherapy combinations, optimizing treatment sequencing, and studying real-world outcomes for patients with GU cancers.